Determining the risk of caries in a patient

Details for Australian Patent Application No. 2002233357 (hide)

Owner 3M ESPE AG

Inventors Bokenkamp, Thomas; Haberlein, Ingo; Wagner, Ingo; Bader-Danziger, Michaela; Steinbeiss, Christian; Guggenberger, Rainer

Agent Shelston IP

Pub. Number AU-B-2002233357

PCT Pub. Number WO2002/068679

Priority 101 08 900.7 23.02.01 DE

Filing date 22 February 2002

Wipo publication date 12 September 2002

Acceptance publication date 1 March 2007

International Classifications

C12Q 1/02 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

C12Q 1/26 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving oxidoreductase

C12Q 1/32 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving dehydrogenase

Event Publications

6 March 2003 Application Open to Public Inspection

  Published as AU-B-2002233357

1 March 2007 Application Accepted

  Published as AU-B-2002233357

19 July 2007 Standard Patent Sealed

17 September 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002233358-Imidazolidine derivatives, their preparation, and their use as antinflamatory agent

2002233356-METHOD AND DEVICE FOR ADAPTING THE SENSITIVITY FOR DETECTING A PARAMETER CARRIED BY A SIGNAL